Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
154
-
Total 13F shares, excl. options
-
41M
-
Shares change
-
+4.07M
-
Total reported value, excl. options
-
$2.39B
-
Value change
-
+$241M
-
Put/Call ratio
-
1.06
-
Number of buys
-
82
-
Number of sells
-
-65
-
Price
-
$58.40
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q1 2017
190 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2017.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 154 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41M shares
of 58.6M outstanding shares and own 69.93% of the company stock.
Largest 10 shareholders include FMR LLC (6.33M shares), WELLINGTON MANAGEMENT GROUP LLP (5.89M shares), BB BIOTECH AG (2.84M shares), Capital International Investors (2.8M shares), VANGUARD GROUP INC (2.6M shares), BlackRock Inc. (2.17M shares), Clearbridge Investments, LLC (1.54M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.4M shares), STATE STREET CORP (1.21M shares), and Flagship Pioneering Inc. (965K shares).
This table shows the top 154 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.